Objectives: This study's objective was to determine if there would be a difference in the intervention rates when using the simple rules management protocol (SRMP) as compared to the Risk of Malignancy Index in the Royal College of Obstetricians and Gynaecologists guideline (RMI/RCOG). Methods: This was a prospective randomised controlled trial with the participants and researchers non-blinded and the surgeons and pathologists blinded. We recruited pain-free postmenopausal women who received an ultrasound diagnosis of an adnexal tumour.
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Women were randomised to either of the two protocols, which then determined if they were offered conservative or surgical management. An intention-to-treat analysis was performed.
The primary outcome measure was rate of surgical interventions for adnexal tumours up to 12 months after randomisation. The secondary outcome measures were the number of staging surgical procedures, surgical complications and number of delayed diagnoses of ovarian cancer. Results: There were 148 women who were randomised over 39 months with 73 in the RMI/RCOG arm and 75 in the SRMP arm with outcome data for 136 at 12 months. The two groups were balanced in terms of age, length of time since menopause and use of hormone replacement therapy.
There were 18/68 (28.1%) women in the RMI/RCOG arm who had surgery versus 7/68 (10.3%) women in the SRMP arm. (P =0.015, χ2 test). The relative risk was 2.57 (95% CI: 1.15 to 5.76) and the difference in these proportions was 16.2% (95% CI: 3.4% to 28.9%). There were no significant differences in the number of staging surgical procedures and in the surgical complications between the two groups. There were no delayed diagnoses of ovarian cancer at 12 months. Conclusions: The surgical intervention rates in asymptomatic postmenopausal women with an ultrasound diagnosis of adnexal tumours are significantly lower when the novel SRMP protocol is used for triaging them when compared to the standard RMI/RCOG protocol and without an increase in delayed malignant diagnoses. 
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